Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia
Trial details
- Registry ID
- NCT04571645
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as 2-0,3-0 desulfated heparin; CX-01; DSTAT; ODSH; dociparstat sodium
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid LeukemiaNCT04571645 | Jazz Pharmaceuticals | Phase 3 | Terminated | 2022-05-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |